UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT) Corporate Rebranding Initiative Reflects New Direction for Company PR...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No...
As filed with the Securities and Exchange Commission on March 29, 2016 Registration No. 333-_________ UNITED...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒...
Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business Updates Company Remains on Track to Deliver Key AEROSURF®...
Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016 PR Newswire WARRINGTON, Pa...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...
| OMB APPROVAL | |_____________________| |OMB NUMBER: | UNITED STATES |EXPIRES: | SECURITIES AND EXCHANGE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads